759 Results

Biosimilars in the EU - Information guide for healthcare professionals

This guide has therefore been prepared with the important objective of providing healthcare professionals with reference information on both the science and regulation underpinning the use of biosimilars.

NRAS position paper on biosimilar medicines – Updated February, 2019

In this position paper we set out our recommendations for a national best practice approach to be taken.

Guideline on good pharmacovigilance practices (GVP)

A biological medicinal product (hereon referred to as ‘biological’) is a medicinal product that contains an active substance that is produced by or extracted from a biological source and that needs for its characterisation and...

Management of cancer-associated disseminated intravascular coagulation: guidance from the SSC of the ISTH.

The pathogenesis of cancer‐associated disseminated intravascular coagulation (DIC) is complex and multifactorial. It could present as a spectrum ranging from clinically asymptomatic, but with laboratory markers of coagulation activation...

The European guideline on management of major bleeding and coagulopathy following trauma: fifth edition.

Background: Severe traumatic injury continues to present challenges to healthcare systems around the world, and post-traumatic bleeding remains a leading cause of potentially preventable death among injured patients.

Diagnosis and treatment of disseminated intravascular coagulation: guidelines of the Italian Society for Haemostasis and Thrombosis (SISET).

Purpose: The Italian Society for Thrombosis and Haemostasis commissioned a project to develop clinical practice guidelines for the diagnosis and treatment of DIC.

Management of coagulopathy associated with postpartum hemorrhage: guidance from the SSC of the ISTH

This document aims to provide a practical and pragmatic approach to the management of coagulopathy associated with PPH, although it is recognized that, due to limited evidence, expert opinion will vary.

Cannabis-based medicinal products

This guideline covers prescribing of cannabis-based medicinal products for people with intractable nausea and vomiting, chronic pain, spasticity and severe treatment-resistant epilepsy.

Familial hypercholesterolaemia: identifification and management

This guideline covers identifying and managing familial hypercholesterolaemia (FH), a specific type of high cholesterol that runs in the family, in children, young people and adults. It aims to help identify people at increased risk of...

Abortion care

This guideline covers care for women of any age (including girls and young women under 18) who request an abortion. It aims to improve the organisation of services and make them easier for women to access.

Load more